cimetidine has been researched along with Respiratory Tract Neoplasms in 2 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Respiratory Tract Neoplasms: New abnormal growth of tissue in the RESPIRATORY SYSTEM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " So far as can be assessed, however, none of these drug-disease associations represented adverse effects of cimetidine treatment; on the contrary, they resulted from cimetidine being used, knowingly or unknowingly, for treating the symptoms of various diseases or for alleviating adverse effects of other agents such as corticosteroids, non-steroidal anti-inflammatory drugs, and radiotherapy." | 1.27 | Postmarketing surveillance of the safety of cimetidine: 12 month mortality report. ( Colin-Jones, DG; Langman, MJ; Lawson, DH; Vessey, MP, 1983) |
| " The 12 month report noted that cimetidine was being given, knowingly or unknowingly, in the late stages of many diseases and also to counter the adverse gastric effects of other drugs used in the treatment of serious disorders." | 1.27 | Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up. ( Colin-Jones, DG; Langman, MJ; Lawson, DH; Vessey, MP, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colin-Jones, DG | 2 |
| Langman, MJ | 2 |
| Lawson, DH | 2 |
| Vessey, MP | 2 |
2 other studies available for cimetidine and Respiratory Tract Neoplasms
| Article | Year |
|---|---|
Postmarketing surveillance of the safety of cimetidine: 12 month mortality report.
Topics: Aged; Alcohol Drinking; Cimetidine; Colonic Neoplasms; England; Esophageal Neoplasms; Evaluation Stu | 1983 |
Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up.
Topics: Aged; Cimetidine; Duodenal Ulcer; Evaluation Studies as Topic; Female; Gastrointestinal Diseases; Ga | 1985 |